Making that choice safely and effectively requires more than general information
Several weight-independent mechanisms may contribute to the cardioprotective effects of GLP-1RAs, including direct vascular and myocardial effects [29], improved plaque stability [29], anti-inflammatory benefits [30], and modulation of prothrombotic [31] and neurohormonal activity [15]
The out-of-pocket costs will still be very cost-prohibitive for most, especially individuals with Medicaid insurance, Thiara said
Most evidence comes from animal models or cellular studies showing improved mitochondrial function
Phase I trials focus on safety, involving a small group of healthy volunteers to determine the optimal dosage and identify any side effects
One in three participants lost at least 20% of their weight, mirroring results seen with the injectable version